.
MergerLinks Header Logo

New Deal


Announced

BioChek to acquire BIOTECON.

Financials

Edit Data
Transaction Value-
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Pharmaceuticals

Merger

Friendly

Germany

Pending

Private

Single Bidder

molecular diagnostics

Acquisition

microbiological diagnostics

Majority

Synopsis

Edit

BioChek, a provider of veterinary diagnostic, agreed to acquire BIOTECON, a molecular and microbiological diagnostics provider. Financial terms were not disclosed. "This allows us to offer a complete diagnostic management solution from Farm to Fork for our customers. Food safety starts with healthy animals. We are proud that with the acquisition of BIOTECON we can now cover the whole chain, starting with the monitoring of animal health, through management of safe processing to the final consumer product," Barend van Dam, BioChek Founder and CEO.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US